Quality monitoring: Survey of the quality of selected antiretroviral medicines circulating in five African countries.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 162
- Publication type:
- Article
Works matching IS 10109609 AND DT 2017 AND VI 31 AND IP 2
Results: 37
1
2
ATC/DDD classification.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 236
- Publication type:
- Article
3
Publications and events.
- Published in:
- 2017
- Publication type:
- Excerpt
4
Quality monitoring: Survey of the quality of selected antiretroviral medicines circulating in five African countries.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 162
- Publication type:
- Article
5
Safety news.
- Published in:
- 2017
- Publication type:
- Excerpt
6
Capillary electrophoresis.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 224
- Publication type:
- Article
7
Proposed revision of the monograph on Atenolol (Atenololum).
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 220
- Publication type:
- Article
8
Proposed revision of the monograph on Capreomycin for injection (Capreomycini ad injectionem).
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 210
- Publication type:
- Article
9
Proposed revision of the monograph on Capreomycin sulfate (Capreomycini sulfas).
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 206
- Publication type:
- Article
10
Mebendazole tablets (Mebendazoli compressi).
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 202
- Publication type:
- Article
11
Transition from microbiological to physicochemical assays in monographs on capreomycin active pharmaceutical ingredients and products.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 214
- Publication type:
- Article
12
Placebo and drug kits in clinical trial design.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 158
- Publication type:
- Article
13
Approved.
- Published in:
- 2017
- Publication type:
- Excerpt
14
Under discussion.
- Published in:
- 2017
- Publication type:
- Excerpt
15
Ingredients catalogue in Australia.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 183
- Publication type:
- Article
16
India builds centralized regulatory portal.
- Published in:
- 2017
- Publication type:
- Excerpt
17
Publication of clinical study reports: Release of EMA documents halted.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 183
- Publication type:
- Article
18
EMA and academia.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 182
- Publication type:
- Article
19
MedDRA expands global reach.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 182
- Publication type:
- Article
20
Swiss--Austrian agreement.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 182
- Publication type:
- Article
21
Report on EMA--FDA assessment pilot.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 182
- Publication type:
- Article
22
EU and African regulators meet.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 181
- Publication type:
- Article
23
Tripartite alignment on requirements for antibacterials.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 181
- Publication type:
- Article
24
New investments in Canada.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 181
- Publication type:
- Article
25
India national action plan.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 180
- Publication type:
- Article
26
Dispensing categories in Switzerland: Revision to encourage self-medication.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 180
- Publication type:
- Article
27
Reporting of shortages in Canada: Now mandatory via new website.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 180
- Publication type:
- Article
28
GMP for compounded medicines.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 180
- Publication type:
- Article
29
Adverse events of illicit drugs in UK: New reporting scheme.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 179
- Publication type:
- Article
30
Pharmacovigilance in Europe: Updates and system upgrade.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 179
- Publication type:
- Article
31
EU medical devices regulation: Strengthened rules.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 178
- Publication type:
- Article
32
EU Priority medicines scheme: One year on.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 178
- Publication type:
- Article
33
Australian orphan drug programme: Reforms and transition arrangements.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 178
- Publication type:
- Article
34
New fast-track pathway in India: WHO-recommended combinations.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 177
- Publication type:
- Article
35
Assessment of generics in China: Demonstrating interchangeability.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 177
- Publication type:
- Article
36
Medicines regulation: Regulating medicine manufacturers: is an on-site inspection the only option?
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 153
- By:
- Publication type:
- Article
37
Proposed International Nonproprietary Names: List 117.
- Published in:
- WHO Drug Information, 2017, v. 31, n. 2, p. 242
- Publication type:
- Article